BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 816573)

  • 1. Reversible asynergy. Histopathologic and electrographic correlations in patients with coronary artery disease.
    Bodenheimer MM; Banka VS; Hermann GA; Trout RG; Pasdar H; Helfant RH
    Circulation; 1976 May; 53(5):792-6. PubMed ID: 816573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local characteristics of the normal and asynergic left ventricle in man.
    Bodenheimer MM; Banka VS; Trout RG; Hermann GA; Pasdar H; Helfant RH
    Am J Med; 1976 Nov; 61(5):650-6. PubMed ID: 984068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of reversible asynergy. The native coronary circulation.
    Banka VS; Bodenheimer MM; Helfant RH
    Circulation; 1975 Nov; 52(5):810-6. PubMed ID: 1080696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asynergy in coronary heart disease. Evolving clinical and pathophysiologic concepts.
    Helfant RH; Bodenheimer MM; Banka VS
    Ann Intern Med; 1977 Oct; 87(4):475-82. PubMed ID: 410336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of ventricular function in coronary artery disease using nitroglycerin and computerized analysis of left ventriculograms.
    Marshall HW; Clayton P; Urie P; Warner H; Liddle HV
    Ann Thorac Surg; 1975 Aug; 20(2):127-35. PubMed ID: 809016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin and ventricular performance. Differential effect in the presence of reversible and irreversible asynergy.
    Shah R; Bodenheimer MM; Banka VS; Helfant RH
    Chest; 1976 Oct; 70(4):473-9. PubMed ID: 824101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nitroglycerin, postextrasystolic potentiation, and pacing-induced ischaemia on wall motion in patients with ischaemic heart disease.
    Schwartz F; Ensslen R; Thormann J; Sesto M
    Br Heart J; 1977 Jan; 39(1):44-52. PubMed ID: 401644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Q waves and ventricular asynergy: predictive value and hemodynamic significance of anatomic localization.
    Bodenheimer MM; Banka VS; Helfant RH
    Am J Cardiol; 1975 May; 35(5):615-8. PubMed ID: 1124715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of echocardiography in determination of reversible posterior wall asynergy.
    Morrison CA; Bodenheimer MM; Feldman MS; Banka VS; Helfant RH
    Am Heart J; 1977 Aug; 94(2):140-5. PubMed ID: 406768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of left ventricular asynergy by nitroglycerin in coronary artery disease.
    Reddy SP; Curtiss EI; O'Toole JD; Matthews RG; Salerni R; Leon DF; Shaver JA
    Am Heart J; 1975 Oct; 90(4):479-86. PubMed ID: 808954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of pathologic Q waves on the standard electrocardiogram and the epicardial electrogram of the human heart.
    Bodenheimer MM; Banka VS; Trout RG; Pasdar H; Helfant RH
    Circulation; 1976 Aug; 54(2):213-8. PubMed ID: 181166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute changes in infranodal conduction time following left ventriculography and sublingual nitroglycerin administration in man.
    Peters RW; Fisher ML; Resnick S; Plotnick GD; Carliner NH; Scheinman MM
    Am Heart J; 1983 Sep; 106(3):464-70. PubMed ID: 6410892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical deterioration of left ventricular asynergy after administration of nitroglycerin.
    Tei C; Chin K; Vijayaraghavan G; Boltwood CM; Shah PM
    Am J Cardiol; 1985 Mar; 55(6):677-9. PubMed ID: 3919552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention ventriculography. Comparative value of nitroglycerin, post-extrasystolic potentiation and nitroglycerin plus post-extrasystolic potentiation.
    Banka VS; Bodenheimer MM; Shah R; Helfant RH
    Circulation; 1976 Apr; 53(4):632-7. PubMed ID: 1253384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects of nitroglycerin during experimental coronary occlusion.
    Levites R; Bodenheimer MM; Helfant RH
    Circulation; 1975 Dec; 52(6):1050-5. PubMed ID: 810264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial activation in patients with coronary artery disease: effects of regional contraction abnormalities.
    Wiener I; Mindich B; Pitchon R; Pichard A; Kupersmith J; Estioko M; Jurado R; Camunas J; Litwak R
    Circulation; 1982 Jan; 65(1):154-60. PubMed ID: 7053276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of total and regional myocardial contractility in determining the indications for aortocoronary shunting].
    Miasnik BN; Iliukhin VV; Andres IuP
    Sov Med; 1991; (9):6-8. PubMed ID: 1798927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic significance of S-T and T wave abnormalities in patients with the intermediate coronary syndrome.
    Bodenheimer MM; Banka VS; Trout RG; Hermann GA; Pasdar H; Helfant RH
    Am J Cardiol; 1977 Feb; 39(2):153-8. PubMed ID: 299974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of nitroglycerin, digoxin and inderal of myocardial asynergy in ischemic heart disease].
    Shevchenko OP; Gasilin VS
    Kardiologiia; 1978 Sep; 18(9):84-9. PubMed ID: 100646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of thallium-201 redistribution scintigraphy in the preoperative differentiation of reversible and nonreversible myocardial asynergy.
    Rozanski A; Berman DS; Gray R; Levy R; Raymond M; Maddahi J; Pantaleo N; Waxman AD; Swan HJ; Matloff J
    Circulation; 1981 Nov; 64(5):936-44. PubMed ID: 6974614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.